In The Lancet Oncology, Joseph C Del Paggio and colleagues1 examine expenditures for the ten drugs with the highest expenditure between 2012 and 2022 in Ontario, Canada. Studies with this level of granularity are rare, and even more so when conducted longitudinally. Pairing these expenditures with clinical outcomes makes these results even more informative and relevant.
[Comment] The cost and value of cancer medicines in Ontario, Canada
For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –
LATEST
Sign up for our emails
Trusted insights straight to your inbox and get the latest updates from OncWeekly
Newsletter
Privacy Policy